Dual-task Training Combined with TDCS on Cognitive-motor Performance and Brain Activity in Stroke Patients
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Jan 9, 2025
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special type of brain stimulation called transcranial direct current stimulation (tDCS) combined with a training program that involves both thinking and moving can help stroke patients. The goal is to see if this combination improves their ability to walk and pedal while doing other tasks at the same time, and how it affects their brain activity.
To participate in this study, you need to be 50 years or older, have experienced a stroke at least six months ago, and be able to follow simple instructions. You should also be able to walk for 10 meters, even if you use a walking aid. However, if you have other neurological disorders, severe pain that affects walking, or a history of seizures, you may not be eligible. If you join the trial, you can expect to take part in training sessions that help improve both your physical and mental skills, while researchers monitor changes in your brain activity. This study is currently recruiting participants, so it could be a valuable opportunity for those looking to improve their recovery after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • a diagnosis of stroke, stroke onset of more than 6 months,
- • aged 50 or more,
- • capable of following verbal and visual instructions,
- • having a Montreal Cognitive Assessment score ≥ 22,
- • able to walk for 10 meters with/without a mobility aid,
- • community-dwelling, unilateral stroke
- Exclusion Criteria:
- • neurological disorders, gait-precluding pain or comorbidity,
- • receiving any formal rehabilitation training,
- • contraindications to exercise (e.g., unstable angina),
- • contraindications to fNIRS, MRI, and tDCS (e.g., brain skin injury, pacemaker, metal implants in the brain),
- • history of seizure or epilepsy,
- • color blindness.
- • unable to walk with/without a mobility aid while responsing stimulus by the remote control
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported